Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals DRC | B3 | Salute | Ricerca medica e biotecnologica | 732,65 Mrd BRL | -254,6x | 2,21 | 686,57 BRL | -2,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regeneron | B3 | Salute | Ricerca medica e biotecnologica | 612,02 Mrd BRL | 24,7x | 95,14 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
IQVIA Holdings BDR | B3 | Salute | Ricerca medica e biotecnologica | 245,66 Mrd BRL | 30,2x | 0,91 | 319,92 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BioNTech SE | B3 | Salute | Ricerca medica e biotecnologica | 151,53 Mrd BRL | -48,7x | 0,47 | 39,40 BRL | -4,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Beigene | B3 | Salute | Ricerca medica e biotecnologica | 128,35 Mrd BRL | -0,69 | 48,91 BRL | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Moderna | B3 | Salute | Ricerca medica e biotecnologica | 118,47 Mrd BRL | -3,5x | 0,01 | 15,61 BRL | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BioTechne | B3 | Salute | Ricerca medica e biotecnologica | 64,35 Mrd BRL | 66,2x | -1,73 | 13,57 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ascendis Pharma AS | B3 | Salute | Ricerca medica e biotecnologica | 42,80 Mrd BRL | -14,8x | -0,71 | 49,50 BRL | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biomm On | B3 | Salute | Ricerca medica e biotecnologica | 1,14 Mrd BRL | -11,7x | -0,47 | 8,90 BRL | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |